Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Existing evidence from randomized controlled trials does not support routine population screening for prostate cancer, a study published online September 14 in the British Medical Journal on concludes. However, a second study also published the same day suggests that a single test at age 60 could identify men who are most likely to develop and die from prostate cancer. These men could then be monitored more closely, while others could be exempt from further screening. Prostate cancer is one of the most common cancers among men worldwide. Screening is widely used in many countries, but it remains controversial because experts can't agree whether the benefits of screening outweigh the potential harms and costs of overdiagnosis and overtreatment of healthy men. In 2006 a review of two randomized controlled trials concluded that there was not enough evidence to support routine prostate cancer screening. Since then, four new trials have been published. So Philipp Dahm, a professor at the University of Florida, and colleagues reviewed all six trials, involving 387,286 participants. They found that screening does aid in the diagnosis of prostate cancer at an earlier stage but does not have a significant impact on mortality and comes at the risk of overtreatment. The authors say there is insufficient evidence to support actively inviting all men in certain age groups to attend screening for prostate cancer (as happens with breast cancer screening for women), and they suggest men should be better informed about the uncertainties associated with screening. In the second study Hans Lilja and colleagues show that a single prostate-specific antigen level test at age 60 strongly predicts a man's lifetime risk of diagnosis and death from prostate cancer. They found that 90% of prostate cancer deaths occurred in men with highest PSA levels at age 60, whereas men with average or low PSA levels had negligible rates of prostate cancer or death by age 85. Their results suggest that at least half of men age 60 and older might be exempted from further prostate cancer screening, which would reduce overdiagnosis and overtreatment. In an accompanying editorial, Gerald Andriole, chief of urologic surgery at Washington University School of Medicine, suggests that PSA testing should be tailored to individual risk. He recommends that young men at high risk of prostate cancer, such as those with a strong family history and higher baseline PSA concentrations, should be followed closely, while elderly men and those with a low risk of disease could be tested less often, if at all. "Approaches such as these will hopefully make the next 20 years of PSA-based screening better than the first 20," he says.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Before AIDS, gay artist Rex drew hot men on the prowl — then he disappeared
April 11 2024 3:15 PM
Diets that mimic fasting reverse aging: study
March 07 2024 5:28 PM
The Most Amazing HIV Allies & Advocates of 2023
November 03 2023 12:51 PM
PrEP without a prescription now a reality in California
February 06 2024 8:37 PM
This OnlyFans Star Is Trying to Raise $100K to Fight HIV
December 26 2023 3:05 PM
Injectable HIV treatment, prevention: Everything you need to know
March 26 2024 3:28 PM
The naked Black body takes center stage in this HIV campaign
January 03 2024 1:07 PM
8 dating tips for gay men from a gay therapist
March 21 2024 2:50 PM
Mr. Gay World wants to make sure you're OK
January 02 2024 4:56 PM
Plus: Featured Video
Latest Stories
The government failed on mpox. Ritchie Torres's new bill addresses that
April 18 2024 1:21 PM
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
Todrick Hall has long supported the communities he comes from
April 17 2024 12:02 PM
Our May/June issue of Plus is here!
April 17 2024 12:00 PM
Giselle Byrd is taking center stage — and helping others do the same
April 10 2024 2:24 PM
Discover endless fun at The Pride Store: Games & electronics for all ages
April 09 2024 4:25 PM
Mean Girls' Daniel Franzese on playing an HIV+ character
April 09 2024 3:57 PM
HIV-positive Air Force, Navy servicemembers victorious in lawsuit
April 09 2024 3:02 PM
Unlocking a new level of beauty with Dr Botanicals' ethical skincare line
April 08 2024 3:40 PM
Unleash your wild side with The Pride Store’s beginner’s guide to kink
April 08 2024 3:35 PM
Why are mpox cases in the U.S. on the rise again?
April 08 2024 1:30 PM
Happy national foreskin day!
April 04 2024 1:45 PM
Adult entertainment icons Derek Kage & Cody Silver lead fight for free speech
April 03 2024 3:06 PM
LGBTQ+ patients twice as likely to face discrimination: survey
April 02 2024 4:57 PM
Spring into The Pride Store’s top new arrivals for April
April 02 2024 4:39 PM
Nashville PD Must Pay HIV-Positive Man Denied a Job
April 01 2024 6:22 PM
Common has a message on how to foster self-love
March 29 2024 7:33 PM
Listen to Dr. Levine: Take syphilis seriously
March 28 2024 6:40 PM
Breaking boundaries in gender-free fashion with Stuzo Clothing
March 27 2024 2:15 PM